4.6 Review

New Drugs Approved in 2020

期刊

AMERICAN JOURNAL OF MEDICINE
卷 134, 期 9, 页码 1096-1100

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.amjmed.2021.03.034

关键词

Accelerated approval; Fast track; Novel drugs; Priority review; US Food and Drug Administration

向作者/读者索取更多资源

In 2020, the US Food and Drug Administration approved 53 novel drugs, with the majority being reviewed and approved through an expedited review pathway, and over half being approved for the treatment of rare diseases.
In 2020, the US Food and Drug Administration approved 53 novel drugs. Thirty-six of the 53 (68%) drugs were reviewed and approved through an expedited review pathway, and 31 of the 53 (58%) were approved for treatment of a rare disease. This review includes a summary of the novel drugs approved by the US Food and Drug Administration in 2020. (C) 2021 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据